---
figid: PMC7838467__10522_2021_9910_Fig2_HTML
figtitle: Rapamycin regulates lifespan primarily through the mTOR signaling pathway
organisms:
- NA
pmcid: PMC7838467
filename: 10522_2021_9910_Fig2_HTML.jpg
figlink: pmc/articles/PMC7838467/figure/Fig2/
number: F2
caption: Rapamycin regulates lifespan primarily through the mTOR signaling pathway.
  mTOR exists mainly in two functionally distinct complexes termed mTORC1 and mTORC2.
  Rapamycin inhibits mTORC1 on an intermittent basis, while long-term administration
  also inhibits mTORC2 in most tissues. Inhibition of mTORC1 promotes protein and
  nucleotide synthesis as well as autophagy responses, while also reducing cellular
  stress responses. These effects of rapamycin may promote longevity. In contrast,
  inhibition of mTORC2 leads to metabolic dysfunction and reduced lifespan, but the
  exact mechanism is unclear
papertitle: 'Aging and age‚Äêrelated diseases: from mechanisms to therapeutic strategies.'
reftext: Zhe Li, et al. Biogerontology. 2021 Jan 27 :1-23.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9617566
figid_alias: PMC7838467__F2
figtype: Figure
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
redirect_from: /figures/PMC7838467__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7838467__10522_2021_9910_Fig2_HTML.html
  '@type': Dataset
  description: Rapamycin regulates lifespan primarily through the mTOR signaling pathway.
    mTOR exists mainly in two functionally distinct complexes termed mTORC1 and mTORC2.
    Rapamycin inhibits mTORC1 on an intermittent basis, while long-term administration
    also inhibits mTORC2 in most tissues. Inhibition of mTORC1 promotes protein and
    nucleotide synthesis as well as autophagy responses, while also reducing cellular
    stress responses. These effects of rapamycin may promote longevity. In contrast,
    inhibition of mTORC2 leads to metabolic dysfunction and reduced lifespan, but
    the exact mechanism is unclear
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - MTOR
  - RPTOR
  - MAPKAP1
  - RICTOR
  - MLST8
  - IRS2
  - IRS1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - RPS6KB1
  - PRKCA
  - AKT1
  - AKT2
  - AKT3
  - ULK1
  - SGK1
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - Crtc
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - S6k
  - Akt
  - Atg1
  - Tpi
  - foxo
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - longevity
  - Rapamycin
---
